RABIMED INTERNATIONAL LIMITED

Company Registration Number:
04497792 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

RABIMED INTERNATIONAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

RABIMED INTERNATIONAL LIMITED

Company Information

for the Period Ended 31 July 2024




Director: Nolitha Mji
Registered office: Unit 61
Battersea Business Centre
99-109 Lavender Hill
London
England
SW11 5QL
Company Registration Number: 04497792 (England and Wales)

RABIMED INTERNATIONAL LIMITED

Balance sheet

As at 31 July 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 108 135
Total fixed assets: 108 135
Current assets
Stocks: 332 413
Debtors: 885 941
Cash at bank and in hand: 87 96
Total current assets: 1,304 1,450
Creditors: amounts falling due within one year: ( 11,196 ) ( 9,202 )
Net current assets (liabilities): ( 9,892 ) ( 7,752 )
Total assets less current liabilities: ( 9,784 ) ( 7,617 )
Total net assets (liabilities): ( 9,784 ) ( 7,617 )

The notes form part of these financial statements

RABIMED INTERNATIONAL LIMITED

Balance sheet continued

As at 31 July 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 2 2
Profit and loss account: ( 9,786 ) ( 7,619 )
Shareholders funds: ( 9,784 ) ( 7,617 )

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 22 August 2024
And Signed On Behalf Of The Board By:

Name: Nolitha Mji
Status: Director

The notes form part of these financial statements

RABIMED INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover represents the value, net of value added tax and discounts, of goods provided to customers.

    Tangible fixed assets depreciation policy

    Depreciation is calculated so as to write off the cost of all fixed assets over their expected useful life.
    The rates applied are:-
    Fixtures, Fittings & Equipment - 20% on written down value.

RABIMED INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

RABIMED INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 3. Off balance sheet disclosure

    No

RABIMED INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Tangible Assets

Total
Cost £
At 01 August 2023 1,397
Additions -
Disposals -
Revaluations -
Transfers -
At 31 July 2024 1,397
Depreciation
At 01 August 2023 1,262
Charge for year 27
On disposals -
Other adjustments -
At 31 July 2024 1,289
Net book value
At 31 July 2024 108
At 31 July 2023 135